{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:27:00Z","timestamp":1778826420686,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.drugpo.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,8,31]],"date-time":"2012-08-31T05:15:23Z","timestamp":1346390123000},"page":"495-497","source":"Crossref","is-referenced-by-count":18,"title":["\u2018Opioid Drought\u2019, Canadian-style? Potential implications of the \u2018natural experiment\u2019 of delisting Oxycontin in Canada"],"prefix":"10.1016","volume":"23","author":[{"given":"Benedikt","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Keates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2012.07.008_bib0005","series-title":"Drug policy and the public good","author":"Babor","year":"2010"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0010","first-page":"256","article-title":"Nonmedical use of opioid analgesics among Ontario students","volume":"56","author":"Brands","year":"2010","journal-title":"Canadian Family Physician"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0015","unstructured":"Centers for Disease Control and Prevention. (2011). Vital signs: Overdoses of prescription opioid pain relievers \u2013 United States, 1999\u20132008 (Rep. No. 60)."},{"key":"10.1016\/j.drugpo.2012.07.008_bib0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpain.2005.05.004","article-title":"Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002\u20132004","volume":"6","author":"Cicero","year":"2005","journal-title":"Journal of Pain"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0025","article-title":"Life after oxy: Addiction services see a rise in client numbers","author":"Clairmont","year":"2012","journal-title":"The Spectator"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2007.08.008","article-title":"Prescription opioid use, misuse, and diversion among street drug users in New York City","volume":"92","author":"Davis","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-5-84","article-title":"The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia","volume":"5","author":"Day","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1747-597X-1-11","article-title":"The \u201clessons\u201d of the Australian \u201cheroin shortage\u201d","volume":"1","author":"Degenhardt","year":"2006","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0045","doi-asserted-by":"crossref","unstructured":"DeSimone, J. (2002). Determinants of drug injection behavior: Economic factors, HIV injection risk and needle exchange programs (Working Paper No. 9350). Retrieved from National Bureau of Economic Research. Website: http:\/\/www.nber.org\/papers\/w9350.pdf","DOI":"10.3386\/w9350"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0050","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1503\/cmaj.090784","article-title":"Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone","volume":"181","author":"Dhalla","year":"2009","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0200","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugpo.2008.02.016","article-title":"Fentanyl use among street drug users in Toronto, Canada: Behavioural dynamics and public health implications","volume":"20","author":"Firestone","year":"2009","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0060","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/pds.2190","article-title":"Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005\u20132010","volume":"20","author":"Fischer","year":"2011","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0065","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/070674371005500909","article-title":"Assessing the prevalence of non-medical prescription opioid use in the general Canadian population: Methodological issues and questions","volume":"55","author":"Fischer","year":"2010","journal-title":"Canadian Journal of Psychiatry \u2013 Revue Canadienne de Psychiatrie"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0070","series-title":"Prescription opioids misuse, harms and control in Canada: A research and policy issues brief for the Department of Justice","author":"Fischer","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1503\/cmaj.060729","article-title":"Changes in illicit opioid use profiles across Canada","volume":"175","author":"Fischer","year":"2006","journal-title":"Canadian Medical Association Journal"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0080","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1475-682X.1981.tb00846.x","article-title":"Cultural action and heroin addiction","volume":"51","author":"Gerstein","year":"1981","journal-title":"Sociological Inquiry"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0085","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1360-0443.2010.02926.x","article-title":"What are the policy lessons of National Alcohol Prohibition in the United States, 1920\u20131933?","volume":"105","author":"Hall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0090","series-title":"Non-medical use of prescription opioids and key co-variates in the Ontario population: Summary report to the Ministry of Health and Long-Term Care","author":"Ialomiteanu","year":"2012"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0095","series-title":"Estimated world requirements for 2012 \u2013 Statistics for 2010 statistical information on narcotic drugs data","author":"International Narcotics Control Board (INCB)","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.297.3.249","article-title":"Opioid prescriptions soar","volume":"297","author":"Kuehn","year":"2007","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230410001704118","article-title":"Impact of the heroin \u2018drought\u2019 on patterns of drug use and drug-related harms","volume":"23","author":"Longo","year":"2004","journal-title":"Drug and Alcohol Review"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0110","unstructured":"MacIntyre, L. (Writer), & Karp, M. (Director). (2012). Time Bomb [Television series episode]. In M. Karp (Producer), The fifth estate. Toronto, ON: Canadian Broadcasting Corporation."},{"key":"10.1016\/j.drugpo.2012.07.008_bib0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2105\/AJPH.79.4.459","article-title":"Determinants of needle sharing among intravenous drug users","volume":"79","author":"Magura","year":"1989","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1753-6405.2007.00007.x","article-title":"High hepatitis C incidence in new injecting drug users: A policy failure?","volume":"31","author":"Maher","year":"2007","journal-title":"Australia and New Zealand Medical Journal"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.36076\/ppj.2010\/13\/401","article-title":"Therapeutic use, abuse, and nonmedical use of opioids: A ten-year perspective","volume":"13","author":"Manchikanti","year":"2010","journal-title":"Pain Physician"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jat\/30.8.603","article-title":"Fentanyl-related deaths in Ontario, Canada: Toxicological findings and circumstances of death in 112 cases (2002\u20132004)","volume":"30","author":"Martin","year":"2006","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0135","series-title":"Prescription drug abuse backgrounder for DGC Mike Metatawabin Political\/Media Campaign on NAN Prescription Drug Abuse State of Emergency","author":"Nishnawbe Aski Nation","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0140","series-title":"News release: NAN chiefs call for immediate assistance as region braces for major health catastrophe","author":"Nishnawbe Aski Nation","year":"2012"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0145","series-title":"Latest data on deaths associated with narcotics in Ontario","author":"Office of the Chief Coronero of Ontario","year":"2011"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0150","article-title":"Toronto public health worried oxycontin addicts could overwhelm detox clinics","author":"Ogilvie","year":"2012","journal-title":"The Toronto Star"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0155","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0160","series-title":"I-Track: Enhanced surveillance of risk behaviours among people who inject drugs \u2013 Phase I Repor","author":"Public Health Agency of Canada","year":"2006"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0165","unstructured":"Purdue Pharma Canada. (2012). Purdue pharma statement on the introduction of oxyneo as a replacement for oxycontin [Press release]. Retrieved from http:\/\/www.purdue.ca\/en\/media-room\/archives"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0955-3959(02)00010-5","article-title":"Social influences on the transition to injection drug use among young heroin sniffers: A qualitative analysis","volume":"13","author":"Sherman","year":"2002","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0175","series-title":"Australian drug trends 2001: Findings of the Illicit Drug Reporting System (IDRS)","author":"Topp","year":"2002"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: Commercial triumph, public health tragedy","volume":"99","author":"van Zee","year":"2009","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jat\/30.3.202","article-title":"Hydromorphone-related fatalities in Ontario","volume":"30","author":"Wallage","year":"2006","journal-title":"Journal of Analytical Toxicology"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0190","article-title":"OxyContin delisting not the answer to opioid addiction, experts say","author":"Weeks","year":"2012","journal-title":"Globe and Mail"},{"key":"10.1016\/j.drugpo.2012.07.008_bib0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1465-3362.2009.00145.x","article-title":"Modelling crack cocaine use trends over 10 years in a Canadian setting","volume":"29","author":"Werb","year":"2010","journal-title":"Drug and Alcohol Review"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395912001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395912001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:02:40Z","timestamp":1643328160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395912001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0955395912001168"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2012.07.008","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}